| scholarly article | Q13442814 |
| P50 | author | Dario C Altieri | Q98158352 |
| P2093 | author name string | Takehiko Dohi | |
| Fang Xia | |||
| P2860 | cites work | Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement | Q22254394 |
| Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin | Q24290497 | ||
| HBXIP functions as a cofactor of survivin in apoptosis suppression | Q24303423 | ||
| Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1 | Q24308005 | ||
| cIAP1 Localizes to the nuclear compartment and modulates the cell cycle | Q24338725 | ||
| Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family | Q24670396 | ||
| CD95's deadly mission in the immune system | Q28142072 | ||
| A structural view of mitochondria-mediated apoptosis | Q28185843 | ||
| Validating survivin as a cancer therapeutic target | Q28201382 | ||
| Separating the anti-apoptotic and mitotic roles of survivin | Q28261657 | ||
| Survivin splice variants regulate the balance between proliferation and cell death | Q28305497 | ||
| A dynamic mechanism for AKAP binding to RII isoforms of cAMP-dependent protein kinase | Q28574420 | ||
| The biochemistry of apoptosis | Q29547741 | ||
| The Bcl2 family: regulators of the cellular life-or-death switch | Q29614982 | ||
| AKAP signalling complexes: focal points in space and time | Q29618533 | ||
| Protein translocation in apoptosis | Q33730384 | ||
| Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase | Q33774328 | ||
| PKA: a portrait of protein kinase dynamics | Q34306110 | ||
| Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. | Q34510622 | ||
| Dissecting the circuitry of protein kinase A and cAMP signaling in cancer genesis: antisense, microarray, gene overexpression, and transcription factor decoy. | Q34741074 | ||
| The essential role of RI alpha in the maintenance of regulated PKA activity | Q34741109 | ||
| Protein kinase A as target for novel integrated strategies of cancer therapy. | Q34741171 | ||
| Competition and compensation: coupled to death in development and cancer | Q34803139 | ||
| Apoptosis-targeted therapies for cancer | Q35057060 | ||
| The AMP-activated protein kinase pathway--new players upstream and downstream. | Q35930365 | ||
| Identification of a tumour suppressor network opposing nuclear Akt function | Q35991130 | ||
| PP2A: the expected tumor suppressor | Q36015508 | ||
| The survival kinases Akt and Pim as potential pharmacological targets | Q36274952 | ||
| Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function | Q36274969 | ||
| The case for survivin as a regulator of microtubule dynamics and cell-death decisions | Q36578149 | ||
| The case for Survivin as mitotic regulator | Q36589633 | ||
| Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. | Q37574259 | ||
| B56-associated protein phosphatase 2A is required for survival and protects from apoptosis in Drosophila melanogaster | Q39674654 | ||
| Protein phosphatase 2A enhances the proapoptotic function of Bax through dephosphorylation | Q40282861 | ||
| An IAP-IAP complex inhibits apoptosis | Q40541576 | ||
| Phosphorylation of Par-4 by protein kinase A is critical for apoptosis | Q40891090 | ||
| Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function | Q43893446 | ||
| Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors | Q45190242 | ||
| Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival | Q73292075 | ||
| Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A | Q77406620 | ||
| A JNK-Dependent Pathway Is Required for TNFα-Induced Apoptosis | Q79129693 | ||
| Molecular basis of AKAP specificity for PKA regulatory subunits | Q79326012 | ||
| P433 | issue | 1 | |
| P921 | main subject | phosphorylation | Q242736 |
| P304 | page(s) | 17-28 | |
| P577 | publication date | 2007-07-01 | |
| P1433 | published in | Molecular Cell | Q3319468 |
| P1476 | title | Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection | |
| P478 | volume | 27 |
| Q24299156 | Acetylation Directs Survivin Nuclear Localization to Repress STAT3 Oncogenic Activity |
| Q35104869 | Akt inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer |
| Q33991166 | Akt-phosphorylated mitogen-activated kinase-activating death domain protein (MADD) inhibits TRAIL-induced apoptosis by blocking Fas-associated death domain (FADD) association with death receptor 4 |
| Q35088734 | Apoptotic cell signaling in cancer progression and therapy |
| Q38408709 | BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients |
| Q39245718 | BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery. |
| Q60922861 | CCAR2/DBC1 and Hsp60 Positively Regulate Expression of Survivin in Neuroblastoma Cells |
| Q36938826 | Cell survival and metastasis regulation by Akt signaling in colorectal cancer |
| Q47140262 | Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells |
| Q33897748 | Cleavage of survivin by Granzyme M triggers degradation of the survivin-X-linked inhibitor of apoptosis protein (XIAP) complex to free caspase activity leading to cytolysis of target tumor cells |
| Q38116267 | Clinico-pathologic relevance of Survivin splice variant expression in cancer |
| Q50334108 | Clinicopathological and functional implications of the inhibitor of apoptosis proteins survivin and XIAP in esophageal cancer |
| Q24647585 | Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90 |
| Q34947555 | Developmental control of apoptosis by the immunophilin aryl hydrocarbon receptor-interacting protein (AIP) involves mitochondrial import of the survivin protein |
| Q24337554 | Differential PKA activation and AKAP association determines cell fate in cancer cells |
| Q34245117 | Down-regulation of the antisense mitochondrial non-coding RNAs (ncRNAs) is a unique vulnerability of cancer cells and a potential target for cancer therapy |
| Q35124104 | Elevated levels of uterine anti-apoptotic signaling may activate NFKB and potentially confer resistance to caspase 3-mediated apoptotic cell death during pregnancy in mice |
| Q37440160 | Enhanced antitumor effect of combined gemcitabine and proton radiation in the treatment of pancreatic cancer. |
| Q39092112 | Epigonal conditioned media from bonnethead shark, Sphyrna tiburo, induces apoptosis in a T-cell leukemia cell line, Jurkat E6-1. |
| Q37682332 | Ezrin expression and cell survival regulation in colorectal cancer |
| Q34998646 | Function of survivin in trophoblastic cells of the placenta |
| Q92155655 | Functional Compartmentalization of HSP60-Survivin Interaction between Mitochondria and Cytosol in Cancer Cells |
| Q35183027 | Histone deacetylase inhibitor belinostat represses survivin expression through reactivation of transforming growth factor beta (TGFbeta) receptor II leading to cancer cell death |
| Q24303954 | Hsp60 regulation of tumor cell apoptosis |
| Q33638504 | IAP regulation of metastasis |
| Q37302745 | IAP-targeted therapies for cancer |
| Q33894754 | Identification of a novel TGFβ/PKA signaling transduceome in mediating control of cell survival and metastasis in colon cancer |
| Q39068603 | In vivo analysis of insulin-like growth factor type 1 receptor humanized monoclonal antibody MK-0646 and small molecule kinase inhibitor OSI-906 in colorectal cancer. |
| Q47607136 | Inhibitors of apoptosis: clinical implications in cancer. |
| Q39630896 | Insulin-like growth factor 1 mediates 5-fluorouracil chemoresistance in esophageal carcinoma cells through increasing survivin stability |
| Q38398348 | Is survivin expression prognostic or predictive in malignant pleural mesothelioma? |
| Q39709805 | Liaisons between survivin and Plk1 during cell division and cell death |
| Q28535017 | Loss of survivin in the prostate epithelium impedes carcinogenesis in a mouse model of prostate adenocarcinoma |
| Q36022236 | MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer |
| Q28384629 | Mitochondria and FOXO3: breath or die |
| Q41279453 | Mitochondrial ASncmtRNA-1 and ASncmtRNA-2 as potent targets to inhibit tumor growth and metastasis in the RenCa murine renal adenocarcinoma model |
| Q28073221 | Mitochondrial cAMP signaling |
| Q38053055 | Mitosis-targeted anti-cancer therapies: where they stand. |
| Q37120385 | Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis |
| Q38040859 | Nanotechnology based platforms for survivin targeted drug discovery |
| Q37302750 | New wirings in the survivin networks |
| Q34997239 | Nuclear survivin and its relationship to DNA damage repair genes in non-small cell lung cancer investigated using tissue array |
| Q34123406 | Phosphorylation of eIF2α at serine 51 is an important determinant of cell survival and adaptation to glucose deficiency. |
| Q33960568 | Prostate cancer regulatory networks |
| Q33337521 | Proteomic analysis of HuH-7 cells harboring in vitro-transcribed full-length hepatitis C virus 1b RNA. |
| Q39884717 | Repression of BIRC5/survivin by FOXO3/FKHRL1 sensitizes human neuroblastoma cells to DNA damage-induced apoptosis |
| Q54960980 | Resveratrol Sensitizes Carfilzomib-Induced Apoptosis via Promoting Oxidative Stress in Multiple Myeloma Cells. |
| Q33379617 | Retracted: HPV16 E7-Dependent Transformation Activates NHE1 through a PKA-RhoA-Iinduced Inhibition of p38alpha |
| Q36105547 | Serum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant Mesothelioma |
| Q38958461 | Silencing of survivin using YM155 inhibits invasion and suppresses proliferation in glioma cells |
| Q94545199 | Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex |
| Q26825700 | Survivin - The inconvenient IAP |
| Q26864567 | Survivin - biology and potential as a therapeutic target in oncology |
| Q35414780 | Survivin and IAP proteins in cell-death mechanisms |
| Q47101674 | Survivin and XIAP expression in distinct tumor compartments of surgically resected gastric cancer: XIAP as a prognostic marker in diffuse and mixed type adenocarcinomas |
| Q55006767 | Survivin as a novel target protein for reducing the proliferation of cancer cells. |
| Q38188377 | Survivin as a preferential target for cancer therapy |
| Q92858954 | Survivin at a glance |
| Q36441625 | Survivin contributes to DNA repair by homologous recombination in breast cancer cells |
| Q42324443 | Survivin expression in human lung cancer and the influence of its downregulation on the biological behavior of human lung cancer cells |
| Q37974867 | Survivin in solid tumors: rationale for development of inhibitors. |
| Q24301054 | Survivin monomer plays an essential role in apoptosis regulation |
| Q33798063 | Survivin mutant protects differentiated dopaminergic SK-N-SH cells against oxidative stress. |
| Q27329571 | Survivin promotes oxidative phosphorylation, subcellular mitochondrial repositioning, and tumor cell invasion |
| Q54639525 | Survivin signalling in the heart |
| Q39262525 | Survivin, a target to modulate the radiosensitivity of Ewing's sarcoma |
| Q55046676 | Survivin, cancer networks and pathway-directed drug discovery. |
| Q37798272 | Survivin: a target from brain cancer to neurodegenerative disease. |
| Q52337636 | TGFβ and IGF1R signaling activate protein kinase A through differential regulation of ezrin phosphorylation in colon cancer cells. |
| Q42323429 | Targeting antisense mitochondrial ncRNAs inhibits murine melanoma tumor growth and metastasis through reduction in survival and invasion factors |
| Q27012954 | Targeting survivin in cancer |
| Q28273083 | Targeting survivin in cancer therapy |
| Q41476516 | Terameprocol (tetra-O-methyl nordihydroguaiaretic acid), an inhibitor of Sp1-mediated survivin transcription, induces radiosensitization in non-small cell lung carcinoma |
| Q34584439 | The detergent-soluble cytoplasmic pool of survivin suppresses anoikis and its expression is associated with metastatic disease of human colon cancer |
| Q92589841 | The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC |
| Q24337784 | Threonine 48 in the BIR domain of survivin is critical to its mitotic and anti-apoptotic activities and can be phosphorylated by CK2 in vitro |
| Q30529353 | Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells |
| Q34313903 | YM155 induces EGFR suppression in pancreatic cancer cells |
| Q34539588 | cAMP initiates early phase neuron-like morphology changes and late phase neural differentiation in mesenchymal stem cells |
| Q54647670 | p21 does not protect cancer cells from apoptosis induced by nongenotoxic p53 activation |
Search more.